BOS Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.7M Sell
6,418
-64
-1% -$65.4K 1.79% 13
2026
Q1
$5.96M Buy
6,482
+109
+2% +$111K 1.52% 16
2025
Q4
$6.85M Sell
6,373
-127
-2% -$121K 1.83% 11
2025
Q3
$4.96M Buy
6,500
+17
+0.3% +$12.7K 1.4% 16
2025
Q2
$5.05M Sell
6,483
-92
-1% -$71.5K 1.61% 15
2025
Q1
$5.43M Buy
6,575
+65
+1% +$54.1K 1.86% 12
2024
Q4
$5.03M Sell
6,510
-275
-4% -$228K 1.8% 14
2024
Q3
$6.01M Sell
6,785
-46
-0.7% -$41.4K 2.21% 10
2024
Q2
$6.18M Sell
6,831
-145
-2% -$116K 2.85% 8
2024
Q1
$5.43M Sell
6,976
-26
-0.4% -$18.5K 2.85% 8
2023
Q4
$4.08M Buy
7,002
+1
+0% +$584 2.8% 5
2023
Q3
$3.76M Sell
7,001
-353
-5% -$182K 2.76% 5
2023
Q2
$3.45M Sell
7,354
-50
-0.7% -$21K 2.68% 6
2023
Q1
$2.54M Buy
7,404
+56
+0.8% +$18.9K 2.12% 11
2022
Q4
$2.69M Buy
+7,348
New +$2.61M 2.4% 12

Other funds holding LLY

BOS Asset Management's LLY Position: Q2 2026 in Review

BOS Asset Management reduced its Eli Lilly (LLY) stake by 0.99% in Q2 2026, selling an estimated $65.4K and leaving 6,418 shares worth $7.7M. The position accounts for 1.79% of the portfolio, ranked #13.

BOS Asset Management first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 1,669 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • BOS Asset Management held 6,418 shares of Eli Lilly worth $7.7M as of Q2 2026.
  • BOS Asset Management sold 64 Eli Lilly shares in Q2 2026, an estimated $65.4K.
  • Eli Lilly made up 1.79% of BOS Asset Management's portfolio in Q2 2026, its #13 holding.
  • BOS Asset Management first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 1,669 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on BOS Asset Management's 13F filing for Q2 2026, filed 13 Jul 2026.